Cargando…
Antineutrophil cytoplasm antibody positivity, kidney impairment, and cholesterol embolization
Autores principales: | Farrah, Tariq E., Dhaun, Neeraj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935665/ https://www.ncbi.nlm.nih.gov/pubmed/33637208 http://dx.doi.org/10.1016/j.kint.2020.08.029 |
Ejemplares similares
-
Antineutrophil Cytoplasmic Antibody and Multiple Sclerosis
por: George, Jason C., et al.
Publicado: (2017) -
A Case of Antineutrophil Cytoplasmic Antibody Vasculitis-Associated Acute Kidney Injury in a Patient With Asymptomatic COVID-19 Infection
por: Chandok, Taruna, et al.
Publicado: (2023) -
Treatment of Aggressive Antineutrophil Cytoplasmic Antibody–Associated Vasculitis With Eculizumab
por: Huizenga, Noah, et al.
Publicado: (2019) -
SARS-CoV-2 Vaccination as a Trigger for Perinuclear Antineutrophil Cytoplasmic Antibodies (p-ANCA) Associated With Rapidly Progressive Glomerulonephritis
por: Cano-Gámez, Tábata, et al.
Publicado: (2022) -
Antineutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis as a Possible Side Effect of COVID-19 Vaccination
por: Noel, Edva, et al.
Publicado: (2022)